Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 7 - Drugs for disorders of the blood or the extracellular fluid
Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065)
03/1998
03/31/1998US5733872 Biologically active peptides from functional domains of bactericidal/permeability-increasing protein and uses thereof
03/31/1998CA1339793C Cyclic analogs of atrial natriuretic peptides
03/26/1998WO1998012334A2 Chimeric, humanized and single chain antibodies to alpha-2-antiplasmin
03/26/1998WO1998012329A2 Composition and method for enhancing fibrinolysis using antibodies to alpha-2-antiplasmin
03/26/1998WO1998012189A1 Method of producing polyphenol-containing compositions
03/26/1998WO1998011896A1 Combination therapy for reducing the risks associated with cardiovascular disease
03/26/1998WO1998011789A1 Flavonol containing food supplements
03/26/1998WO1998006400A3 Pharmaceutical products for curing and preventing illnesses connected with the malfunction of vascular endothelial cells
03/26/1998DE19704301C1 Human endoglin gene promoter
03/26/1998CA2266341A1 Composition and method for enhancing fibrinolysis using antibodies to alpha-2-antiplasmin
03/26/1998CA2266339A1 Chimeric, humanized and single chain antibodies to alpha-2-antiplasmin
03/26/1998CA2265827A1 Combination therapy for reducing the risks associated with cardiovascular disease
03/25/1998EP0830381A1 Chitin hydrogels, methods of their production and use
03/25/1998EP0830372A1 Cyclic prodrugs of peptides and peptide nucleic acids having improved metabolic stability and cell membrane permeability
03/25/1998EP0830371A1 IMIDAZO 1,5a]PYRIDINE DERIVED SERINE PROTEASE INHIBITORS
03/25/1998CN1177299A Certain 1, 4, 5 -tri- substituted imidazole compounds useful as cytokine
03/25/1998CN1176812A Implantation under skin type traditional Chinese patent styptic medicine
03/24/1998US5731432 Inhibitors of adenosine monophosphate deaminase
03/24/1998US5731346 Use of omega-3-fatty acids
03/24/1998US5731328 Administering 2-phenyl-3-aroylbenzothiophene compounds to a patient
03/24/1998US5731324 Glycoprotein IIb/IIIa antagonists
03/24/1998US5731315 Inhibitors of factor xa
03/24/1998US5731311 N,N-di(aryl) cyclic urea derivatives as anti-coagulants
03/24/1998US5731308 N,N-di(aryl) cyclic urea derivatives as anti-coagulants
03/24/1998US5731306 Mercaptoacetylamido 1,3,4,5-tetrahydro-benzo c!azepin-3-one disulfide derivatives useful as inhibitors of enkephalinase and ace
03/24/1998US5731289 Bridged dipeptide compounds which have a stimulating activity on cell division, especially in myelopoietic and bone marrow cells
03/24/1998US5731151 Tuberculosis vaccine
03/20/1998CA2185950A1 Process for preparing intermediates for thrombin inhibitors
03/19/1998WO1998011109A1 Novel tricyclic compounds for the inhibition of the ice/ced-3 protease family of enzymes
03/19/1998WO1998011094A1 Benzamidine derivatives substituted by cyclic amino acid or cycl ic hydroxy acid derivatives and their use as anti-coagulants
03/19/1998WO1998010783A1 Muc-1 as an immunosuppressive therapeutic agent for the treatment of inflammatory and autoimmune conditions
03/19/1998WO1998010763A1 Thrombin inhibitors
03/19/1998WO1998001158A3 Haemoglobin-hydroxyethyl starch conjugates as oxygen carriers
03/19/1998CA2264748A1 Muc-1 as an immunosuppressive therapeutic agent for the treatment of inflammatory and autoimmune conditions
03/19/1998CA2264521A1 Benzamidine derivatives substituted by cyclic amino acid or cyclic hydroxy acid derivatives and their use as anti-coagulants
03/19/1998CA2264037A1 Thrombin inhibitors
03/19/1998CA2237314A1 Novel tricyclic compounds for the inhibition of the ice/ced-3 protease family of enzymes
03/18/1998EP0829481A1 Morphinan hydroxamic acid compounds
03/18/1998EP0828759A1 Process of high purity albumin production
03/18/1998EP0828737A1 Isoxazoline and isoxazole derivatives as integrin receptor antagonists
03/18/1998EP0828724A1 Diaryl-5-oxygenated-2-(5h)-furanones as cox-2 inhibitors
03/18/1998CN1037773C Heteroatoms-containing tricyclic compounds
03/17/1998US5728819 Secreted proteins and polynucleotides encoding them
03/17/1998US5728702 Bronchodilator agents, antiallergens or antiplatelet druggs
03/17/1998US5728697 N,N-di(aryl) cyclic urea derivatives as anti-coagulants
03/17/1998US5728674 Polypeptides as anticoagulants
03/17/1998US5728564 U-PA mutants resistant to inhibition by their cognate inhibitors
03/17/1998US5728553 High purity albumin and method of producing
03/17/1998US5728549 Gene expression vectors with controlling sequences of dna
03/17/1998CA1339737C Fibrin-specific and fibrinogen-specific monoclonal antibodies and their derivation from immunized germ free mice
03/17/1998CA1339724C Anti-inflammatory factor, method of isolation, and use
03/12/1998WO1998009948A2 Nitric ester derivatives and their use in urinary incontinence and other diseases
03/12/1998WO1998009647A2 Cyanidin compositions and therapeutic and diagnostic uses therefor
03/12/1998WO1998009629A1 Crystalline pharmaceutical product
03/12/1998WO1998009626A1 Methods for in vivo reduction of iron levels and compositions useful therefor
03/12/1998WO1998009533A1 Cocoa components, edible products having enhanced polyphenol content, methods of making same and medical uses
03/12/1998WO1997046682A3 Polynucleotides from human adult PBMC encoding secreted proteins
03/12/1998CA2795629A1 Cocoa components, edible products having enhanced polyphenol content, methods of making same and medical uses
03/12/1998CA2264607A1 Crystalline pharmaceutical product
03/12/1998CA2264081A1 Nitric ester derivatives and their use in urinary incontinence and other diseases
03/12/1998CA2263686A1 Methods for in vivo reduction of iron levels and compositions useful therefor
03/11/1998EP0827751A2 Medicinal composition containing tissue plasminogen activator and nicotinamide
03/11/1998EP0827749A2 Peritoneal dialysis solution
03/11/1998EP0827748A2 Peritoneal dialysis solution
03/11/1998EP0710279A4 Yolk sac stem cells and their uses
03/11/1998CN1175953A Novel dipeptide amidines as thrombin inhibitors
03/11/1998CN1175572A Ortho-substd. benzoyl guanidine, its preparing method, use thereof and medicine contg. same
03/10/1998US5726198 N,N-di(aryl) cyclic urea derivatives as anti-coagulants
03/10/1998US5726192 Platelet aggregation inhibiting compounds
03/10/1998US5726185 Binding of adhesive proteins to blood platelet aggregation and cell to cell adhesion
03/10/1998US5726173 Anticoagulants
03/10/1998US5726036 Granulocyte-macrophage colony-stimulating factor receptor and derivatives thereof
03/05/1998WO1998008956A2 Use of a mutated macrolide binding protein for the prevention of gvhd
03/05/1998WO1998008850A1 Spirocyclic metalloprotease inhibitors
03/05/1998WO1998008847A1 Substituted 6,5-hetero-bicyclic derivatives
03/05/1998WO1998008811A1 Cyclic amine derivatives
03/05/1998WO1998008537A1 Enhanced stimulation of erythropoiesis
03/05/1998WO1998008529A1 Method of inhibiting fibrosis with a somatostatin agonist
03/05/1998WO1998008528A1 Method of inhibiting fibrosis with a somatostatin agonist
03/05/1998WO1998008518A1 Compositions and methods for administering integrin receptor antagonists
03/05/1998WO1998002548A3 Infectious papillomavirus pseudoviral particles
03/05/1998WO1998001554A3 Secreted proteins and polynucleotides encoding them
03/05/1998WO1998001552A3 Secreted proteins and polynucleotides encoding them
03/05/1998WO1997037688A3 Pharmaceutical combination containing a compound having angiotensin ii and antagonistic activity
03/05/1998DE19729641A1 Antihämolytische liposomale Zubereitung und Verfahren zu deren Herstellung Antihemolytic liposomal preparation and methods for their preparation
03/05/1998CA2264309A1 Method of inhibiting fibrosis with a somatostatin agonist
03/05/1998CA2264044A1 Spirocyclic metalloprotease inhibitors
03/05/1998CA2263998A1 Compositions and methods for administering integrin receptor antagonists
03/05/1998CA2263978A1 Enhanced stimulation of erythropoiesis
03/05/1998CA2263951A1 Use of a mutated macrolide binding protein for the prevention of gvhd
03/04/1998EP0826966A2 Method for stabilizing platelets
03/04/1998EP0826965A1 Method for producing a factor V depleted plasma
03/04/1998EP0826680A1 Dihydronaphthalene and naphthalene compounds, intermediates, formulations, and methods
03/04/1998EP0826670A1 Naphthalene compounds, intermediates, formulations, and methods
03/04/1998EP0826064A1 Low oxygen affinity mutant hemoglobin
03/04/1998EP0826004A1 Storage stable hemoglobin solutions
03/04/1998EP0825994A1 Amidine derivatives useful as anti-platelet aggregation inhibitors and vasodilators
03/04/1998CN1175259A Low molecular weight bicyclic thrombin inhibitors
03/04/1998CN1175254A Piperidineacetic acid derivatives useful as fibrinogen antagonist agent
03/04/1998CN1174835A Salts of ethyl 3 -(2 -(4 -(4 -(amino-imino-methyl) phenyl) -4 -methyl -2, 5 -dioxo -imidazolidin -1 -yl) acetylamino) -3 -phenylpropionate
1 ... 557 558 559 560 561 562 563 564 565 566 567 568 569 570 571 572 573 574 575 576 577 ... 671